Netherlands· NL-6457fbbc5c2e

Posela 3 mg, tabletten

A ivermectin product containing ivermectine, registered in Netherlands by Substipharm. The same ATC class is registered in 15 of our 19 countries.

ATC P02CF01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ivermectineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ivermectin is registered in 15 of 19 countries.

Countries holding a registration under ATC P02CF01 (ivermectin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search ivermectin products by name

Ivermectin · ATC P02CF01

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: IVERMECTINE
Manufacturer: Substipharm
Country: Netherlands (NL)
ATC code: P02CF01
ATC class: Ivermectin
Defined daily dose: 12 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
126402

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for ivermectin.

Graded by severity as the source publishes them — 84 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ivermectin against other medicines How interaction checks work

Ivermectin · interactions on record

111 records

84 moderate
2 minor
25 info

Most severe, free to view

AprepitantA04AD12moderate
LonafarnibA16AX20moderate
DicoumarolB01AA01moderate
WarfarinB01AA03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ivermectin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivermectin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Ivergelan, Ivermectin Stada
Belgium · Cesora, Ivermectin Eg
Bulgaria · Ивермектин, Скабал
Cyprus · Scaball, Soolantra
Czechia · Ivermektin Aristo, Loutol
Germany · Driponin, Iveraxiro
Denmark · Ivermectin Medical Valley, Ivermectin Newbury
Estonia · Ivermectin Orion, Soolantra
Spain · Ivercare, Ivergalen
Finland · Ivermectin Glenmark, Ivermectin Medical Valley
France · Bibovel, Cesora
United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
Greece · Scaball, Soolantra
Hungary · Soolantra
Ireland · Iverscab, Soolantra
Iceland · Ivermcetin Stada, Ivermectin Medical Valley
Italy · Efacti, Ivercare
Lithuania · Ivermectin Orion, Soolantra
Luxembourg · Ivermectin Eg, Ivermectin Substipharm
Latvia · Ivermectin Orion, Ivermectine Orion
Malta · Soolantra
Norway · Ivermectin Glenmark, Ivermectin Medical Valley
Poland · Ivermectin Medical Valley, Ivermectin Orion
Portugal · Ivergalen, Ivermectina Cantabria
Romania · Soolantra
Sweden · Cesora, Efrinter
Slovakia · Ivermectin Exeltis, Soolantra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bfb8a5aa-b96f-4d33-9dc0-e7c98627d851
GET /v1/drugs/bfb8a5aa-b96f-4d33-9dc0-e7c98627d851?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126402_smpc.pdf",
  "strength": null,
  "atc_label": "Ivermectin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126402",
  "excipients": [
    "BUTYLHYDROXYANISOL (E 320)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "IVERMECTINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126402.pdf",
  "authorised_at": "2021/04/14",
  "procedure_number": "NL/H/5117/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126402",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ivermectin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console